Deva Holding ASIST:DEVA -2.83%63 Pretax Margin % is 9.25% as of Mar. 2026, which is 36% below its 10-year median of 14.49. GuruFocus rates IST:DEVA with a GF Score™ of 63/100 and a GF Value™ of ₺81.37 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 956 Drug Manufacturers companies, Deva Holding AS ranks worse than 64.85% on this metric.
The historical rank and industry rank for Deva Holding AS's Pretax Margin % or its related term are showing as below:
IST:DEVA'
s Pretax Margin % Range Over the Past 10 Years
Min: -0.48 Med: 14.49 Max: 49.71
Current: 1.19
IST:DEVA's Pretax Margin % is ranked worse than 64.85% of 956
companies
in the Drug Manufacturers industry
Industry Median: 7.285
vs IST:DEVA: 1.19
Deva Holding AS (IST:DEVA) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Deva Holding AS Pretax Margin % Related Terms
Deva Holding AS Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Deva Holding AS's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IST:DEVA vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Deva Holding AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deva Holding AS Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deva Holding AS's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Deva Holding AS's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Deva Holding AS (IST:DEVA) has a Pretax Margin % of 9.25% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Deva Holding AS and its competitors. This is 36% below median its historical median of 14.49. According to the industry distribution chart, Deva Holding AS ranks #620 out of 956 companies in the Drug Manufacturers industry, placing it in the top 64.9%.
Is Deva Holding AS's Pretax Margin % too high?
Deva Holding AS's current Pretax Margin % of 9.25% is 36% below median its 10-year median of 14.49. The Drug Manufacturers industry median Pretax Margin % is 7.29. Deva Holding AS's value of 9.25% is 27% above this industry median. Based on the distribution chart, Deva Holding AS ranks #620 out of 956 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Deva Holding AS has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deva Holding AS's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Deva Holding AS ranks #620 out of 956 companies for Pretax Margin %. This places Deva Holding AS in the lower half of its industry. The industry median Pretax Margin % is 7.29. Deva Holding AS's value of 9.25% is 27% above this benchmark. While the company's 10-year median is 14.49 vs. the industry median of 7.29, Deva Holding AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.29, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Deva Holding AS's current Pretax Margin % of 9.25% is 27% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Deva Holding AS and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deva Holding AS's current Pretax Margin % is 9.25%, which is 36% below median its own 10-year median of 14.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deva Holding AS stock overvalued right now?
Based on GuruFocus' analysis, Deva Holding AS (IST:DEVA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺81.37, compared to a current price of ₺68.65 — trading 15.6% below its estimated fair value. The current Pretax Margin % is 9.25%, which is 36% below median its 10-year median of 14.49 and 27% above the Drug Manufacturers industry median of 7.29. Deva Holding AS's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Deva Holding AS (IST:DEVA), the current Pretax Margin % is 9.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deva Holding AS (IST:DEVA) Overvalued in 2026?
Based on GuruFocus' analysis, Deva Holding AS stock appears to be undervalued.
The current stock price of ₺68.65 is trading 15.6% below its estimated GF Value™ of ₺81.37.
GuruFocus considers Deva Holding AS to be Modestly Undervalued.
Key valuation signals for IST:DEVA:
Pretax Margin %: 9.25% (36% below median its 10-year median of 14.49)
GF Value™: ₺81.37 vs. price of ₺68.65 (15.6% below fair value)
Industry Position: 27% above the Drug Manufacturers median (#620 of 956)
No single metric tells the full story. See the IST:DEVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
63GF Score
Get the complete analysis for IST:DEVA
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:DEVA has been successfully added to your 
